We can be tempted to push ourselves when we’re feeling OK and having a not-so-bad day with pulmonary hypertension (PH). Plans with family, weekends packed with activities, or even the excitement of feeling better than usual can make us want to do it all. But those of us with…
Read more
Corsair Pharma successfully completed preclinical studies testing its skin patch delivery system for treprostinil as a treatment for pulmonary arterial hypertension (PAH), and is now planning to launch a Phase 1 clinical trial in the next few months. That’s according to new updates from the U.S.-based company, which…
People with coarctation of aorta, or COA — a condition marked by narrowing where the body’s largest blood vessel connects to the heart — are at high risk of developing pulmonary hypertension (PH), and this risk increases as time goes on, a study showed. The data also showed that…
Get regular updates to your inbox.
